Hieronymus Doorenbos - Publications

Affiliations: 
1965-1991 University of Groningen, Groningen, Netherlands 
Area:
Endocrinology

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1991 Dullaart RP, Groener JE, Dikkeschei BD, Erkelens DW, Doorenbos H. Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile. Diabetes Care. 14: 338-41. PMID 2060438 DOI: 10.2337/diacare.14.4.338  0.733
1990 Dullaart RP, Hoogenberg K, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins. European Journal of Clinical Investigation. 20: 581-7. PMID 2127747 DOI: 10.1111/j.1365-2362.1990.tb01904.x  0.715
1990 Dullaart RP, Meijer S, Sluiter WJ, Doorenbos H. Renal haemodynamic changes in response to moderate hyperglycaemia in type 1 (insulin-dependent) diabetes mellitus. European Journal of Clinical Investigation. 20: 208-13. PMID 2112486 DOI: 10.1111/j.1365-2362.1990.tb02270.x  0.3
1989 Dullaart RP, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids. Diabetologia. 32: 14-9. PMID 2707515 DOI: 10.1007/BF00265398  0.738
1984 van Ballegooie E, Hooymans JM, Timmerman Z, Reitsma WD, Sluiter WJ, Schweitzer NM, Doorenbos H. Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care. 7: 236-42. PMID 6734393 DOI: 10.2337/Diacare.7.3.236  0.685
1984 Van Ballegooie E, Reitsma WD, Sluiter WJ, Doorenbos H. Feasibility and efficacy of long-term treatment by continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes. The Netherlands Journal of Medicine. 27: 185-92. PMID 6427640  0.711
1983 Sluiter WJ, Sijperda A, Piers DA, Reitsma WD, Fleuren GJ, Oosterhuis JW, Vermey A, Doorenbos H. [The thyroglobulin level in blood: a reliable indicator of metastasis in the follow-up study of patients with functioning thyroid carcinoma]. Nederlands Tijdschrift Voor Geneeskunde. 127: 1133-8. PMID 6888573  0.615
1983 van der Geest S, Sluiter WJ, Doorenbos H, Reitsma WD. Tamoxifen and prolactin secretion in postmenopausal women with advanced breast cancer. The Netherlands Journal of Medicine. 26: 99-103. PMID 6855993  0.598
1983 van Ballegooie E, Reitsma WD, Sluiter WJ, Doorenbos H. [Improvement of diabetes mellitus in patients practicing self monitoring and management under outpatient supervision]. Nederlands Tijdschrift Voor Geneeskunde. 127: 44-50. PMID 6338403  0.64
1982 van Ballegooie E, Sluiter WJ, Reitsma WD, Doorenbos H. [Pumps for insulin infusion]. Nederlands Tijdschrift Voor Geneeskunde. 126: 67-9. PMID 7054734  0.693
1980 de Jong PE, Donker AJ, van der Wall E, Erkelens DW, van der Hem GK, Doorenbos H. Effect of indomethacin in two siblings with a renin-dependent hypertension, hyperaldosteronism and hypokalemia. Nephron. 25: 47-52. PMID 7352042 DOI: 10.1159/000181752  0.667
1980 van Ballegooie E, Sluiter WJ, Reitsma WD, Doorenbos H. [The treatment of diabetes mellitus using continuous subcutaneous infusion]. Nederlands Tijdschrift Voor Geneeskunde. 124: 2038-42. PMID 7003403  0.656
1980 Sluiter WJ, van Essen LH, Reitsma WD, Doorenbos H. Glycosylated haemoglobin and iron deficiency. Lancet (London, England). 2: 531-2. PMID 6105577 DOI: 10.1016/s0140-6736(80)91853-x  0.585
1976 Sluiter WJ, Erkelens DW, Terpstra P, Reitsma WD, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes. 25: 245-9. PMID 773722 DOI: 10.2337/diab.25.4.245  0.758
1976 Sluiter WJ, Erkelens DW, Reitsma WD, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading. Diabetes. 25: 241-4. PMID 773721 DOI: 10.2337/diab.25.4.241  0.755
1974 Piers DA, Sluiter WJ, Reitsma WD, Doorenbos H. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin. The Netherlands Journal of Medicine. 17: 234-8. PMID 4465730  0.687
1974 De Vries O, Sluiter WJ, Reitsma WD, Doorenbos H. Effect of weight reduction on insulin responsiveness and triglyceride levels in patients with endogenous hypertriglyceridaemia. The Netherlands Journal of Medicine. 17: 212-19. PMID 4465727  0.692
1970 Terpstra P, Reitsma WD, Visser JW, Doorenbos H. The influence of an oral contraceptive on glucose-, F.F.A.-, triglyceride- and insulin levels after glucose loading. Folia Medica Neerlandica. 13: 44-50. PMID 5422992  0.686
1969 de Lange WE, Reitsma WD, Visser JW, Doorenbos H. [The effect of treatment of hyperthyroidism and myxedema on glucose assimilation and the response of free fatty acids and insulin following intravenous glucose administration]. Nederlands Tijdschrift Voor Geneeskunde. 113: 649-53. PMID 5767965  0.7
1964 REITSMA WD, JANSZ A, STRACKEE J, DOORENBOS H. [CORRELATION BETWEEN THE GROWTH HORMONE PICTURE AND THE BEHAVIOR OF FREE FATTY ACIDS AND BLOOD SUGAR CONTENT, DURING FASTING AND AFTER THE USE OF GLUCOSE, PROTEIN OR FAT]. Nederlands Tijdschrift Voor Geneeskunde. 108: 960-2. PMID 14170806  0.666
1963 JANSZ A, DOORENBOS H, REITSMA WD. Effect of food intake on growth-hormone level. Lancet (London, England). 1: 250-1. PMID 13957442 DOI: 10.1016/s0140-6736(63)90957-7  0.607
1962 REITSMA WD, BOSCHMAN TA, DOORENBOS H. [Effect of species-specific growth hormone on a change in the fat metabolism in patients with hypophyseal insufficiency]. Nederlands Tijdschrift Voor Geneeskunde. 106: 2296-9. PMID 13981549  0.624
Show low-probability matches.